Litcius/Paper detail

Combination of ZEN-3694 with CDK4/6 inhibitors reverses acquired resistance to CDK4/6 inhibitors in ER-positive breast cancer

Olesya A. Kharenko, Reena G. Patel, Cyrus Calosing, Edward H. van der Horst

2021Cancer Gene Therapy32 citationsDOI

Topics & Concepts

PalbociclibBromodomainCyclin-dependent kinase 6Cell growthCancer researchMedicineDownregulation and upregulationPharmacologyCell cycleEstrogen receptorEpigeneticsKinaseCyclin D1CancerBreast cancerInternal medicineBiologyMetastatic breast cancerBiochemistryGeneAdvanced Breast Cancer TherapiesProtein Degradation and InhibitorsHistone Deacetylase Inhibitors Research
Combination of ZEN-3694 with CDK4/6 inhibitors reverses acquired resistance to CDK4/6 inhibitors in ER-positive breast cancer | Litcius